Page 81 - GPD-3-2

Gene & Protein in Disease Opportunities and challenges of HIF-1 in cancer

doi: 10.1242/jcs.00427 doi: 10.1111/bph.13079
59. Weidemann A, Breyer J, Rehm M, et al. HIF-1α activation 69. Yang Y, Lu H, Chen C, Lyu Y, Cole RN, Semenza GL. HIF-1
results in actin cytoskeleton reorganization and modulation interacts with TRIM28 and DNA-PK to release paused
of Rac-1 signaling in endothelial cells. Cell Commun Signal. RNA polymerase II and activate target gene transcription in
2013;11(1):80. response to hypoxia. Nat Commun. 2022;13(1):316.
doi: 10.1186/1478-811x-11-80 doi: 10.1038/s41467-021-27944-8
60. Singh AK, Arya RK, Maheshwari S, et al. Tumor 70. Lyu Y, Yang Y, Talwar V, et al. Hypoxia-inducible factor
heterogeneity and cancer stem cell paradigm: Updates in 1 recruits FACT and RNF20/40 to mediate histone
concept, controversies and clinical relevance. Int J Cancer. ubiquitination and transcriptional activation of target genes.
2014;136(9):1991-2000. Cell Rep. 2024;43(4):113972.
doi: 10.1002/ijc.28804 doi: 10.1016/j.celrep.2024.113972
61. Lan L, Luo Y, Cui D, et al. Epithelial-mesenchymal transition 71. Fleyshman D, Prendergast L, Safina A, et al. Level
triggers cancer stem cell generation in human thyroid cancer of fact defines the transcriptional landscape and
cells. Int J Oncol. 2013;43(1):113-120. aggressive phenotype of breast cancer cells. Oncotarget.
doi: 10.3892/ijo.2013.1913 2017;8(13):20525-20542.
62. Luo Y, Cui X, Zhao J, et al. Cells susceptible to epithelial- doi: 10.18632/oncotarget.15656
mesenchymal transition are enriched in stem-like 72. Hirota K, Semenza GL. Regulation of hypoxia-inducible
side population cells from prostate cancer. Oncol factor 1 by prolyl and asparaginyl hydroxylases. Biochem
Rep. 2013;31(2):874-884. Biophys Res Commun. 2005;338(1):610-616.
doi: 10.3892/or.2013.2905 doi: 10.1016/j.bbrc.2005.08.193
63. Schwab LP, Peacock DL, Majumdar D, et al. Hypoxia- 73. Harada H. How can we overcome tumor hypoxia in radiation
inducible factor 1α promotes primary tumor growth and therapy? J Radiat Res. 2011;52(5):545-556.
tumor-initiating cell activity in breast cancer. Breast Cancer
Res. 2012;14(1):R6. doi: 10.1269/jrr.11056
doi: 10.1186/bcr3087 74. Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC
induces expression of hypoxia-inducible factor 1 (HIF-1)
64. Zhu H, Wang D, Zhang L, et al. Upregulation of autophagy by and transcription of genes encoding vascular endothelial
hypoxia-inducible factor-1α promotes EMT and metastatic growth factor and enolase 1: Involvement of HIF-1 in tumor
ability of CD133+ pancreatic cancer stem-like cells during progression. Cancer Res. 1997;57(23):5328-5335.
intermittent hypoxia. Oncol Rep. 2014;32(3):935-942.
75. Zhu B, Cao X, Zhang W, et al. MicroRNA‐31‐5p enhances the
doi: 10.3892/or.2014.3298 Warburg effect via targeting FIH. FASEB J. 2019;33(1):545-556.
65. Giannoni E, Parri M, Chiarugi P. EMT and oxidative stress: doi: 10.1096/fj.201800803r
A bidirectional interplay affecting tumor malignancy.
Antioxid Redox Signal. 2012;16(11):1248-1263. 76. Li SJ, Liu HL, Tang SL, Li XJ, Wang XY. MicroRNA-150
regulates glycolysis by targeting von hippel-lindau in glioma
doi: 10.1089/ars.2011.4280
cells. Am J Transl Res. 2017;9(3):1058-1066.
66. Calvani M, Comito G, Giannoni E, Chiarugi P. Time- 77. Goto Y, Zeng L, Yeom CJ, et al. UCHL1 provides diagnostic
dependent stabilization of hypoxia inducible factor-1α by and antimetastatic strategies due to its deubiquitinating
different intracellular sources of reactive oxygen species. effect on HIF-1α. Nat Commun. 2015;6(1):6153.
PLoS One. 2012;7(10):e38388.
doi: 10.1038/ncomms7153
doi: 10.1371/journal.pone.0038388
78. Zeng L, Morinibu A, Kobayashi M, et al. Aberrant
67. Cho KH, Choi MJ, Jeong KJ, et al. A ROS/STAT3/HIF-1α IDH3α expression promotes malignant tumor growth by
signaling cascade mediates EGF-induced TWIST1 inducing HIF-1-mediated metabolic reprogramming and
expression and prostate cancer cell invasion. Prostate. angiogenesis. Oncogene. 2014;34(36):4758-4766.
2014;74(5):528-536.
doi: 10.1038/onc.2014.411
doi: 10.1002/pros.22776
79. Nakashima R, Goto Y, Koyasu S, et al. UCHL1-HIF-1 axis-
68. Seebacher NA, Richardson DR, Jansson PJ. Glucose
modulation induces reactive oxygen species and increases mediated antioxidant property of cancer cells as a therapeutic
P-glycoprotein-mediated multidrug resistance to target for radiosensitization. Sci Rep. 2017;7(1):6879.
chemotherapeutics. Br J Pharmacol. 2015;172(10):2557-2572. doi: 10.1038/s41598-017-06605-1

Volume 3 Issue 2 (2024) 14 doi: 10.36922/gpd.3431